Since the overexpression of TIGAR inhibits glycolysis, cancer cells tend to use a compensatory energy-providing pathway to increase ATP production and sustain the survival and progression of ESCC via activating AMPK. The gene discussed is TIGAR; the disease is esophageal squamous cell carcinoma.